Erenumab 70 mg + GALCANEZUMAB + ATOGEPANT + EPTINEZUMAB for migraine disorders

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 17 Jun 2026: Trial registered, NCT07655440

The trials

NCT07655440: Comparing Migraine Preventive Therapies vs. Anti-CGRP Therapies for Tinnitus in Patients With Migraine (COMPACT-PM)

State
Not started
Phase
Phase 4
People
120 planned
Started
Jul 2026
Primary completion
Jul 2031
Arms
CGRP-Targeting Therapy
Results
None posted
  1. 17 Jun 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.